To The Moon

1. NuBank | $Nu Holdings Ltd.(NU)$

Niche：LatAm fintech $NU has rapidly become one of largest fintechs globally, let alone in LatAm.

- In Q3, $NU added 5.2 million new customers. They are completely dominant in Brazil where they now have over 100 million customers.

- They added 13% of their Mexico customer base in Q3 alone.

- Mature accounts in Brazil now have an ARPAC of $25 (far higher than the average of $11) which shows the stickiness of the platform over time.

Image

2. TransMedics | $TransMedics Group, Inc.(TMDX)$

- The recent investor day was very strong. Management stated that their goal is FAR more than 10,000 transplants annually.

- The new Command Center at HQ highlights the complete control that $TMDX have over the entirety of their logistics. No other competitor has this.

- They have big plans for international expansion and kidney transplants over the next few years.

Image

3. Amazon | $Amazon.com(AMZN)$ :

Niche: Cloud (and a lot more)

- They are the current leader in Cloud, which is a must own industry for every investor. Estimates are upwards of $350 billion in cloud revenue by 2032.

- Building their own chip which will massively help margins and reduce reliance on $NVDA.

- Have ~1 million robots currently which will lead to further margin expansion.

Image

4. Grab | $Grab Holdings(GRAB)$ :

Niche: Superapp / Southeast Asia

- In Mobility and Delivery, $GRAB are completely dominant in Southeast Asia where they are 4x larger than the nearest competitor.

- They have $UBER's backing too.

- 2/3rds of Southeast Asia's market is unbanked meaning the potential for the financial services platform is huge.

- They have incredible cross-selling capabilities.

Image

5. Celsius | $Celsius Holdings, Inc.(CELH)$

Niche: Energy drinks

- $CELH is growing ~10% quicker than the wider energy drink market.

- They are the leading energy drink brand on Amazon.

- In the channels where they do not sell through Pepsi, $CELH are continuing to grow very well.

- I don't believe this Pepsi inventory issue will continue for too long and I think investor expectations have now been recalibrated.

Image

6. Hims & Hers | $Hims & Hers Health Inc.(HIMS)$ :

Niche: Telehealth

- I believe $HIMS will reach 10M subscribers by 2030 which could lead to $16 billion in revenue based on a 15% CAGR in average monthly revenue figures.

- That would be $16 billion in pure recurring monthly revenue.

- MedMatch (their LLM) will continue to improve over time which will increase personalization and improve efficiency.

- The $HIMS moat is much larger than people think purely because of personalization. - The avenues for growth are huge with international expansion and product expansion.

Image

7. Tesla | $Tesla Motors(TSLA)$ :

Niche: Robotics / Robotaxi / Energy / EV's

- The energy segment is one of the underrated segments of $TSLA that is ignored by a lot of investors. This is a high growth segment that is already profitable.

- The AV market is expected to grow at 33% CAGR for the next decade.

- The robotics segment is a high-risk, high-reward play but Musk believes this will be the highest valued part of $TSLA.

Image

8. Rocket Lab | $Rocket Lab USA, Inc.(RKLB)$ :

Niche:Space

- Much more than just a small satellite company

- $RKLB secured an $8m study contract with the US Airforce Research Lab

- $RKLB also has $320m+ (launch services) and $720m+ (space systems) of backlog of which 50% will be converted to revenue in the next 12 months.

- This backlog is up 80% YoY

Image

9. United Health Group | $UnitedHealth(UNH)$ :

Niche:Health Care

- Arguably the cheapest defensive, strong moat, recession proof stock in the market today.

- Despite the fatal recent news, the company is still performing extremely well. In Q3 alone, they added more than 2 million new commercial customers, and fulfilled 1.6 billion prescriptions.

- Optum Health and Optum Rx have added over $7 billion to revenues.

- EPS growth targets of 13%-16% annually.

Image

10. ASML | $ASML Holding NV(ASML)$:

Niche:Semiconductors

- $ASML is now flat YTD and down 30% in the last 6 months. - I have no doubt that they have one of the strongest moats in the entire market.

- $ASML demand will remain high for the next 10-20 years

- There is of course a risk having a large portion of revenue from China and Taiwan, but those areas are innovating just like the US. Demand will stay strong there too. Here's why the $ASML moat is so large

Image